CTRI Number |
CTRI/2023/10/058679 [Registered on: 16/10/2023] Trial Registered Prospectively |
Last Modified On: |
14/10/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Use of fentanyl vs dexmedetomide as adjuvant to 0.5% Bupivacaine hyperbaric in spinal anaesthesia for total hip replacement surgeries. |
Scientific Title of Study
|
Comperative study of dexmedetomidine and fentanyl as an adjuvant to 0.5% Bupivacaine in spinal anesthesia in patient under going for total hip replacement surgeries. |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Ved jain |
Designation |
Pg resident |
Affiliation |
peoples college of medical sciences and research center |
Address |
First floor Anaesthesia department Peoples hospital pcms campus bhopal
Bhopal MADHYA PRADESH 462037 India |
Phone |
8802977828 |
Fax |
|
Email |
vedjain2004@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
Name |
ABHILEKH JAIN |
Designation |
Professor |
Affiliation |
peoples college of medical sciences and research center |
Address |
Room 1 anaesthesia department first floor peoples hospital PCMS CAMPUS BHOPAL
Bhopal MADHYA PRADESH 462037 India |
Phone |
9827606268 |
Fax |
|
Email |
jainabhilekh@rediffmail.com |
|
Details of Contact Person Public Query
|
Name |
VED JAIN |
Designation |
PG RESIDENT |
Affiliation |
peoples college of medical sciences and research center |
Address |
Room no 1 First floor anaesthesia department PCMS CAMPUS BHOPAL
Bhopal MADHYA PRADESH 462037 India |
Phone |
8802977828 |
Fax |
|
Email |
vedjain2004@yahoo.co.in |
|
Source of Monetary or Material Support
|
Anaesttesia department 1st floor Peoples college of Medical Science and research center bhopal |
|
Primary Sponsor
|
Name |
Peoples college of medical science |
Address |
Peoples college of medical science Peoples campus Bhanpur bhopal |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Ved jain |
Peoples hospital |
First floor anaesthesia department peoples hospital bhopal Bhopal MADHYA PRADESH |
08802977828
vedjain2004@yahoo.co.in |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Dexmedetomidine |
Using dexmedetomidine as an adjuvant to o.5% Bupivacaine heavy for spinal anaesthesia in total hip replacement surgeries for 3 hours |
Comparator Agent |
FENTANYL |
Adding fentanyl as an adjuvant to o.5% bupivacaine heavy in spinal anesthesia pt under going for total hip replacement surgeries for 3 hours |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
90.00 Year(s) |
Gender |
Both |
Details |
1 Age > 18 years
2 ASA grade1 and 2
3 Scheduled for elective total Hip replacement surgeries under subarachnoid block.
|
|
ExclusionCriteria |
Details |
1Lack of patient’s consent.
2 Age <18yrs
3 ASA grade 3 and more.
4 Patients with local skin site infections.
5 Patients with hypersensitivity to any of the drugs used.
- Pregnant and lactating mothers.
- History of serious pulmonary disease, ischemic heart disease, renal/hepatic dysfunction, coronary artery, or cervical spine disease and patients with abnormal coagulation profile.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
|
Primary Outcome
|
Outcome |
TimePoints |
Post operative relief in pain |
5 hrs |
|
Secondary Outcome
|
Outcome |
TimePoints |
Heart rate changes |
5 hours |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 4 |
Date of First Enrollment (India)
|
30/10/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
We will be comparing two adjuvant dexmedetomidine and fentanyl when added to 0.5% Bupivacaine in patient posted for tolat hip replacement surgeries in spinal anaesthesia for purpose of trial. Since there are no such study has been done in Central india. |